AsiaOligonucleotide, Peptide
Shanghai Waigaoqiao, China
Discovery Synthesis for Oligonucleotide, Peptide & Conjugate Pre-formulation & Formulation Development for Oligonucleotides, Peptides & Conjugates
Site detail
Europe
Couvet, Neuchâtel, Switzerland
Drug Product Manufacturing for Oligonucleotides, Peptides & Conjugates
Drug Product Manufacturing for Oligonucleotides, Peptides & Conjugates
- Rue du Pré-Jorat 14, 2108 Couvet, Switzerland
The site manufactures oral drug drug product to 8 different countries and regions. It offers oral solid drug product manufacturing, along with packaging and labeling capabilities.
In the next 2-3 years, we plan to double the current manufacturing and packaging capacities. The site will also add injectable manufacturing lines, lipid nanoparticle capabilities, and spray dried dispersion to support new modalities such as oligonucleotide and peptide drug product manufacturing.
Our Couvet site has successfully passed numerous inspections by the US FDA, Japan’s PMDA, and SwissMedic.
Site Virtual Tour
Site Related News
WuXi AppTec’s Couvet Site Receives EcoVadis 2024 Silver Medal Rating
Couvet, Switzerland - November 14, 2024 - WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enabl...
WuXi STA Completes Acquisition of Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland
State-of-the-art facility significantly enhances WuXi STA's drug product capacity in Europe while better enabling global customers
New York & S...
WuXi STA to Purchase Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland
NEW YORK & SHANGHAI -- Bristol Myers Squibb (NYSE: BMY) and WuXi STA -...
WuXi AppTec’s Couvet Site Receives EcoVadis 2024 Silver Medal Rating
Couvet, Switzerland - November 14, 2024 - WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enabl...
WuXi STA Completes Acquisition of Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland
State-of-the-art facility significantly enhances WuXi STA's drug product capacity in Europe while better enabling global customers
New York & S...
WuXi STA to Purchase Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland
NEW YORK & SHANGHAI -- Bristol Myers Squibb (NYSE: BMY) and WuXi STA -...
Nearby in the network
Other sites
AsiaOligonucleotide, Peptide
Changzhou, China
API Process Development and Manufacturing for Oligonucleotides, Peptides & Conjugates
Site detail
AsiaOligonucleotide, Peptide
Wuxi City, China
Pre-formulation, Formulation Development & Manufacturing for Oligonucleotides, Peptides & Conjugates
Site detail
How can we help?
Our TIDES drug experts stand ready.
Tell us where your molecule is today — discovery, CMC, or commercial supply — and we will map the fastest credible route to patients.
Small molecule projects? WuXi STA